Author: Morgridge Institute for Research

Detecting cellular diversity to sharpen personalized cancer treatments

Melissa Skala, a University of Wisconsin–Madison associate professor of biomedical engineering, and collaborators have used an approach called optical metabolic imaging (OMI) to effectively assess that heterogeneity and related treatment responses in organoids created with tissues from patients with breast cancer and pancreatic cancer.

The Power List 2020

Stem cell pioneer and Morgridge investigator James Thomson was named to the Power List 2020 for his contributions to advancing the field of medicine to save lives and improve the world.

We’re in this together

Morgridge CEO Brad Schwartz provides an update on how we’re keeping scientists and teams safe during the COVID-19 pandemic.